Sign in Pull a receipt

IPSC

Century Therapeutics, Inc.

Healthcare · Biotechnology

$237.76 sample

-1.66 (-0.69%) 1D

Market cap

$629.5B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-23

Alerts

8

Price$237.76 +12.02% 3M daily closessample

239.42210.98

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23SEC10-Q filed
Oct 15SEC8-K filed: material event
Oct 07SECForm 144 filed
Oct 01INSInsider buy: Chief Executive Officer
Sep 25INSInsider buy: Director
Sep 17INSInsider sell: Chief Financial Officer
Sep 08INSInsider buy: 10% owner
Sep 03INSInsider buy: Director

Sign up to see the real IPSC record →

Company facts

SEC EDGAR registration

Name: Century Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +2sample, -100 to +100
Reporting currency: USD

Who is positioning in IPSC

sample

Insiders: 24 insider transactions over 90 days, net selling, $607.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 21 funds hold $6.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.7B +15.3% y/y

Q4 2024Q3 2026

Inventory$11.3B +15.5% y/y

Q4 2024Q3 2026

Accounts receivable$8.3B +9.7% y/y

Q4 2024Q3 2026

Total debt$23.7B +16.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $129.0B -4.2% 3M
Sample peer B: $427.4B +10.1% 3M
Sample peer C: $499.8B +8.0% 3M
Sample peer D: $279.6B -9.1% 3M
Sample peer E: $445.7B +6.4% 3M